Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus

PHASE4TerminatedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Barrett's EsophagusHigh Grade DysplasiaLow Grade Dysplasia
Interventions
DEVICE

CryoSpray Ablation System (510(k) NO: K070893)

no drug interventions specified

Trial Locations (16)

10032

Columbia University Medical Center, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

17604

Lancaster Reginal Medical Center, Lancaster

19107

Thomas Jefferson University Hospital, Philadelphia

21201

University of Maryland Medical Center, Baltimore

27599

Universtiy of North Carloina at Chapel Hill, Chapel Hill

27708

Duke University Medical Center, Durham

33612

H. Lee Moffitt Cancer Center, Tampa

44195

Cleveland Clinic Foundation, Cleveland

75246

Baylor University, Dallas

92868

University of California -Irvine, Orange

06856

Norwalk Hospital, Norwalk

02118

Boston Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

07030

Hoboken Universtiy Medical Center, Hoboken

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSA Medical, Inc.

INDUSTRY

NCT00526786 - Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus | Biotech Hunter | Biotech Hunter